Hepatocellular carcinoma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with ASA status of II-III, aged 18-65 years, BMI between 18 to 28kg/m2 who are scheduled for hepatectomy under general anesthesia.
Exclusion criteria
Exclusion criteria: Patients with previous abdominal surgery, endocrine or immune system diseases(eg. diabetes, thyroid disorder or rheumatic disease), treatment with adrenocortical hormone, non-steroidal anti-inflammatory drugs or other agents affecting immunity before surgery, previous chemotherapy treatment, who are allergic to any drugs used in this trial, NYHA III or ?, history of metastasis through intrahepatic vessels or other organs, infection in puncture sites and etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Neutrophil-lymphocyte ratio;Concentration of extracellular vesicles and the expression of miRNA within them;VAS score; | — |
Secondary
| Measure | Time frame |
|---|---|
| classification of complications after surgery;The first postoperative exhaust time;Length of stay; | — |
Countries
China
Contacts
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College